Cargando…

Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study

BACKGROUND: In dual antiplatelet therapy (DAPT), low-dose acetylsalicylic acid is combined with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of bleeding. Guidelines on DAPT recommend using this combination for a limited period of between three weeks and 30 months. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moerlie, Ashwin R., van Uden, Renate C., Mantel-Teeuwisse, Aukje K., Van Den Bemt, Patricia, Becker, Matthijs L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centro de Investigaciones y Publicaciones Farmaceuticas 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308913/ https://www.ncbi.nlm.nih.gov/pubmed/32587641 http://dx.doi.org/10.18549/PharmPract.2020.2.1803

Ejemplares similares

Compliance of Disease Awareness Campaigns in Printed Dutch Media with National and International Regulatory Guidelines
por: Leonardo Alves, Teresa, et al.
Publicado: (2014)

Systematic reviews of ten pharmaceutical pricing policies – a research protocol
por: Tordrup, David, et al.
Publicado: (2020)

Unintentional guideline deviations in hospitalized patients with two or more antithrombotic agents: an intervention study
por: van Uden, Renate C. A. E., et al.
Publicado: (2021)

Sustainable Development Goal indicator for measuring availability and affordability of medicines for children: a proof-of-concept study
por: Joosse, Iris R, et al.
Publicado: (2023)

Impact of regulatory requirements on medicine registration in African countries – perceptions and experiences of pharmaceutical companies in South Africa
por: Narsai, Kirti, et al.
Publicado: (2012)

Longitudinal study of Good Pharmacy Practice roles covered at the annual world pharmacy congresses 2003–2019
por: Kusynová, Zuzana, et al.
Publicado: (2022)

Implementation of a Patient Questionnaire in Community Pharmacies to Improve Care for Patients Using Combined Antithrombotic Therapy: A Qualitative Study
por: van Uden, Renate C. A. E., et al.
Publicado: (2023)

Alignment between outcomes and minimal clinically important differences in the Dutch type 2 diabetes mellitus guideline and healthcare professionals’ preferences
por: Dankers, Marloes, et al.
Publicado: (2021)

Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study
por: Sagwa, Evans L, et al.
Publicado: (2014)

Missing data on accessibility of children’s medicines
por: Joosse, Iris R, et al.
Publicado: (2022)

Healthcare workers’ perspectives on access to sexual and reproductive health services in the public, private and private not-for-profit sectors: insights from Kenya, Tanzania, Uganda and Zambia
por: Ooms, Gaby I., et al.
Publicado: (2022)

Evidence on the effectiveness of policies promoting price transparency - A systematic review
por: Joosse, Iris R., et al.
Publicado: (2023)

Synergy between health technology assessments and clinical guidelines for multiple sclerosis
por: Hogervorst, Milou A., et al.
Publicado: (2023)

Newer long-acting insulin prescriptions for patients with type 2 diabetes: prevalence and practice variation in a retrospective cohort study
por: Dankers, Marloes, et al.
Publicado: (2022)

Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisements
por: Dankers, Marloes, et al.
Publicado: (2023)

Assessing the impact of law enforcement to reduce over-the-counter (OTC) sales of antibiotics in low- and middle-income countries; a systematic literature review
por: Jacobs, Tom G., et al.
Publicado: (2019)

Access to sexual and reproductive health commodities in East and Southern Africa: a cross-country comparison of availability, affordability and stock-outs in Kenya, Tanzania, Uganda and Zambia
por: Ooms, Gaby I., et al.
Publicado: (2020)

Availability, prices and affordability of UN Commission’s lifesaving medicines for reproductive and maternal health in Uganda
por: Kibira, Denis, et al.
Publicado: (2017)

Are drugs prescribed rationally and according to standard guidelines in India?
por: Beedimani, Ravindra S.
Publicado: (2011)

National medicines policies – a review of the evolution and development processes
por: Hoebert, Joëlle M, et al.
Publicado: (2013)

Donor Commitments and Disbursements for Sexual and Reproductive Health Aid in Kenya, Tanzania, Uganda and Zambia
por: Kibira, Denis, et al.
Publicado: (2021)

Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists
por: Bazargani, Yaser T., et al.
Publicado: (2014)

Characteristics of drugs safety signals that predict safety related product information update
por: Insani, Widya N., et al.
Publicado: (2018)

The double opioid crisis: A call for balance
por: Vranken, Marjolein J.M., et al.
Publicado: (2019)

Access to oxytocin and misoprostol for management of postpartum haemorrhage in Kenya, Uganda and Zambia: a cross-sectional assessment of availability, prices and affordability
por: Kibira, Denis, et al.
Publicado: (2021)

A comparative human rights analysis of laws and policies for adolescent contraception in Uganda and Kenya
por: Perehudoff, Katrina, et al.
Publicado: (2022)

Availability, affordability and stock-outs of commodities for the treatment of snakebite in Kenya
por: Ooms, Gaby Isabelle, et al.
Publicado: (2021)

A multifaceted intervention to reduce guideline non-adherence among prescribing physicians in Dutch hospitals
por: Bos, Jacqueline M., et al.
Publicado: (2017)

Price changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil
por: Santa-Ana-Tellez, Yared, et al.
Publicado: (2015)

Five-year trends in treatment changes in an adult cohort of HIV/AIDS patients in Ghana: a retrospective cohort study
por: Ankrah, Daniel N. A., et al.
Publicado: (2017)

When Reality Does Not Meet Expectations—Experiences and Perceived Attitudes of Dutch Stakeholders Regarding Payment and Reimbursement Models for High-Priced Hospital Drugs
por: Callenbach, Marcelien H. E., et al.
Publicado: (2022)

Are Antibiotics Prescribed to Inpatients According to Recommended Standard Guidelines in South Sudan? A Retrospective Cross-Sectional Study in Juba Teaching Hospital
por: Otim, Michael E, et al.
Publicado: (2021)

The burden of adverse events during treatment of drug-resistant tuberculosis in Namibia
por: Sagwa, Evans, et al.
Publicado: (2012)

Co-prescription of Dual-Antiplatelet Therapy and Proton Pump Inhibitors: Current Guidelines
por: Saven, Hannah, et al.
Publicado: (2022)

Essential Medicines Are More Available than Other Medicines around the Globe
por: Bazargani, Yaser T., et al.
Publicado: (2014)

Real World Data in Health Technology Assessment of Complex Health Technologies
por: Hogervorst, Milou A., et al.
Publicado: (2022)

Perspectives on how to build bridges between regulation, health technology assessment and clinical guideline development: a qualitative focus group study with European experts
por: Hogervorst, Milou A, et al.
Publicado: (2023)

Trends in access to anti‐malarial treatment in the formal private sector in Uganda: an assessment of availability and affordability of first‐line anti‐malarials and diagnostics between 2007 and 2018
por: Kibira, Denis, et al.
Publicado: (2021)

Adverse events and patients’ perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia
por: Sagwa, Evans L, et al.
Publicado: (2016)

The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study
por: Jacobs, Tom G., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rt79s2ed2q0h0bb26rvqdudcgn